View in EDS HTML Full Text PDF Full Text

The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer.

Saved in:
Bibliographic Details
Title: The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer.
Authors: Mulugeta P; Division of Nuclear Medicine Imaging and Therapy, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, United States., Dorff T; City of Hope Comprehensive Cancer Center, Duarte, CA 91010, United States., Hafron J; Michigan Institute of Urology, Troy, MI 48084, United States., Huynh MA; Massachusetts General Brigham Cancer Institute, Boston, MA 02115, United States.; Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Department of Radiation Oncology, Harvard Medical School, Boston, MA 02115, United States., Morgans AK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States., Ross AE; Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States., McKay RR; Department of Medicine, Urology, and Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA 92093, United States.
Source: The oncologist [Oncologist] 2026 Jun 06; Vol. 31 (7).
Publication Type: Journal Article; Review
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42112615
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mulugeta+P%22">Mulugeta P</searchLink>; Division of Nuclear Medicine Imaging and Therapy, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, United States.<br /><searchLink fieldCode="AU" term="%22Dorff+T%22">Dorff T</searchLink>; City of Hope Comprehensive Cancer Center, Duarte, CA 91010, United States.<br /><searchLink fieldCode="AU" term="%22Hafron+J%22">Hafron J</searchLink>; Michigan Institute of Urology, Troy, MI 48084, United States.<br /><searchLink fieldCode="AU" term="%22Huynh+MA%22">Huynh MA</searchLink>; Massachusetts General Brigham Cancer Institute, Boston, MA 02115, United States.; Dana-Farber Cancer Institute, Boston, MA 02215, United States.; Department of Radiation Oncology, Harvard Medical School, Boston, MA 02115, United States.<br /><searchLink fieldCode="AU" term="%22Morgans+AK%22">Morgans AK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215, United States.<br /><searchLink fieldCode="AU" term="%22Ross+AE%22">Ross AE</searchLink>; Northwestern University Feinberg School of Medicine, Chicago, IL 60611, United States.<br /><searchLink fieldCode="AU" term="%22McKay+RR%22">McKay RR</searchLink>; Department of Medicine, Urology, and Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA 92093, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229607837%22">The oncologist</searchLink> [Oncologist] 2026 Jun 06; Vol. 31 (7).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9607837 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-490X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210837159%22">10837159 </searchLink><i>NLM ISO Abbreviation: </i>Oncologist <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42112615
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/oncolo/oyag173
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: The emerging role of prostate-specific membrane antigen-targeted radioligand therapy in metastatic hormone-sensitive prostate cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mulugeta P
      – PersonEntity:
          Name:
            NameFull: Dorff T
      – PersonEntity:
          Name:
            NameFull: Hafron J
      – PersonEntity:
          Name:
            NameFull: Huynh MA
      – PersonEntity:
          Name:
            NameFull: Morgans AK
      – PersonEntity:
          Name:
            NameFull: Ross AE
      – PersonEntity:
          Name:
            NameFull: McKay RR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 06
              Text: 2026 Jun 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1549-490X
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: The oncologist
              Type: main
ResultId 1